News

Zorvolex was approved in October 2013 by the US Food and Drug Administration (FDA) for the treatment of mild to moderate acute pain in adults. Iroko president and

The most recent order for TapouT-branded products was for Go4ITNutrition.com. Go4ITNutrition is an online marketplace that deals specifically in sports supplements and sports nutrition products. The website features

Earlier in March 2013, the company had submitted the marketing authorization application (MAA) to the TGA for review of Latuda. Lurasidone is an atypical antipsychotic agent, developed by

Around 16 chronic HBV patients will be enrolled in multi-center, randomized, double-blind, placebo-controlled, dose-escalation Phase IIa trial, which is being conducted at Queen Mary Hospital and Prince of

According to the company, the new product is shipped as a flow-through and will be available at all existing retailers, including major drugstores CVS, Walgreens and Rite-Aid, mass

Initially, the company aims to develop and manufacture hemp and THC-free formulations that create medicinal compounds that don’t produce the ‘high’ associated with cannabis containing THC. Scientific research

Aspyrian has received an exclusive license from the National Cancer Institute for a new ADC technology platform, Near-infrared Photoimmunotherapy (PIT), which is expected to offer highly efficient and

Pursuant to the terms of the agreement, AMRI will acquire all the outstanding shares of Cedarburg Pharmaceuticals for $38.2m in cash. The transaction, including $2.8m of assumed liabilities,

The FDA Division of Anesthesia and Analgesia Products agreed to a 505(b) regulatory pathway to obtain market approval for the product. The company anticipates initiating the pivotal pharmacokinetic